Compare · DE vs MLAB
DE vs MLAB
Side-by-side comparison of Deere & Company (DE) and Mesa Laboratories Inc. (MLAB): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DE and MLAB operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- DE is the larger of the two at $161.22B, about 297.9x MLAB ($541.1M).
- DE has been more active in the news (3 items in the past 4 weeks vs 1 for MLAB).
- DE has more recent analyst coverage (25 ratings vs 3 for MLAB).
- Company
- Deere & Company
- Mesa Laboratories Inc.
- Price
- -
- -
- Market cap
- $161.22B
- $541.1M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 3
- 1
- Recent ratings
- 25
- 3
Deere & Company
Deere & Company, together with its subsidiaries, manufactures and distributes various equipment worldwide. The company operates through three segments: Agriculture and Turf, Construction and Forestry, and Financial Services. The Agriculture and Turf segment provides various agriculture and turf equipment, and related service parts, including large, medium, and utility tractors; tractor loaders; combines, cotton pickers, cotton strippers, and sugarcane harvesters; harvesting front-end equipment; sugarcane loaders and pull-behind scrapers; tillage, seeding, and application equipment comprising sprayers, nutrient management, and soil preparation machinery; self-propelled forage harvesters and attachments, balers, and mowers; riding lawn equipment, golf course equipment, utility vehicles, and commercial mowing equipment along with associated implements; integrated agricultural solutions and precision technologies; and other outdoor power products. The Construction and Forestry segment offers a range of machines and service parts used in construction, earthmoving, road building, material handling, and timber harvesting, including backhoe loaders; crawler dozers and loaders; four-wheel-drive loaders; excavators; motor graders; articulated dump trucks; landscape loaders; skid-steer loaders; milling machines; recyclers; slipform pavers; surface miners; asphalt pavers; compactors; tandem and static rollers; mobile crushers and screens; mobile and stationary asphalt plants; log skidders; feller bunchers; log loaders; log forwarders; and log harvesters and related logging attachments. The Financial Services segment finances sales and leases agriculture and turf, and construction and forestry equipment. It also offers wholesale financing to dealers of the foregoing equipment; and extended equipment warranties, as well as finances retail revolving charge accounts. Deere & Company was founded in 1837 and is headquartered in Moline, Illinois.
Mesa Laboratories Inc.
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The company's Instruments segment designs, manufactures, and markets quality control hardware and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. This segment's products include dialysate meters and calibration solutions, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company's Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Continuous Monitoring segment designs, develops, and markets systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Latest DE
- Deere & Company filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form FWP filed by Deere & Company
- John Deere Reinforces Commitment to Diagnostic and Repair Tools for Farmers Under Agreement with FTC and States
- Deere & Company filed SEC Form 8-K: Leadership Update
- SEC Form 10-Q filed by Deere & Company
- Oppenheimer reiterated coverage on Deere with a new price target
- Deere & Company Announces Quarterly Dividend
- Thoughtworks Recognized as John Deere Partner-Level Supplier in 2026 Achieving Excellence Program
- Deere Reports Second Quarter Net Income of $1.773 Billion
- Deere & Company filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
Latest MLAB
- MESA LABS DECLARES QUARTERLY DIVIDEND
- CAO Crennen Lyndsey Elizabeth sold $39,560 worth of shares (442 units at $89.50), exercised 726 shares at a strike of $95.10 and was granted 263 shares, increasing direct ownership by 37% to 2,020 units (SEC Form 4)
- SVP Operations Archbold Brian David exercised 3,324 shares at a strike of $95.10, was granted 1,859 shares and sold $225,187 worth of shares (2,516 units at $89.50), increasing direct ownership by 72% to 6,377 units (SEC Form 4)
- CFO Sakys John exercised 3,792 shares at a strike of $95.10, was granted 2,282 shares and sold $253,022 worth of shares (2,827 units at $89.50) as part of a pre-agreed trading plan, increasing direct ownership by 20% to 19,785 units (SEC Form 4)
- SVP Operations Archbold Brian David sold $116,558 worth of shares (1,151 units at $101.27), decreasing direct ownership by 24% to 3,710 units (SEC Form 4)
- CAO Crennen Lyndsey Elizabeth sold $11,950 worth of shares (118 units at $101.27), decreasing direct ownership by 7% to 1,473 units (SEC Form 4)
- CFO Sakys John sold $123,850 worth of shares (1,223 units at $101.27), decreasing direct ownership by 7% to 16,538 units (SEC Form 4)
- New insider Crennen Lyndsey Elizabeth claimed ownership of 1,863 shares (SEC Form 3)
- SVP Operations Archbold Brian David exercised 2,454 shares at a strike of $104.08, increasing direct ownership by 102% to 4,861 units (SEC Form 4)
- CFO Sakys John exercised 2,717 shares at a strike of $104.08, increasing direct ownership by 18% to 17,761 units (SEC Form 4)